MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
3.680
+0.170 (4.84%)
At close: Feb 18, 2026, 4:00 PM EST
3.680
0.00 (0.00%)
After-hours: Feb 18, 2026, 4:00 PM EST
MDxHealth Market Cap
MDxHealth has a market cap or net worth of $189.02 million as of February 18, 2026. Its market cap has increased by 113.76% in one year.
Market Cap
189.02M
Enterprise Value
244.91M
1-Year Change
113.76%
Ranking
Category
Stock Price
$3.68
Market Cap Chart
Since the IPO on May 12, 2017, MDxHealth's market cap has decreased from $269.23M to $189.02M, a decrease of -29.79%. That is a compound annual growth rate of -3.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 189.02M | 6.97% |
| Dec 31, 2025 | 176.71M | 57.67% |
| Dec 31, 2024 | 112.07M | 4.24% |
| Dec 29, 2023 | 107.52M | 659,987.71% |
| Dec 29, 2022 | 16.29K | -99.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| May 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 936.60M |
| Personalis | 799.24M |
| Fulgent Genetics | 721.50M |
| Myriad Genetics | 407.34M |
| Prenetics Global | 337.58M |
| Burning Rock Biotech | 322.89M |
| Insight Molecular Diagnostics | 171.02M |
| FONAR | 121.41M |